From: Yokukansan (TJ-54) for treatment of pervasive developmental disorder not otherwise specified and Asperger’s disorder: a 12-week prospective, open-label study
Sociodemographic and clinical variables
Value
Sex, N (male/female)
22/18
Age, mean±SD, years
22.7 ± 7.3
IQ
88.9 ± 7.3